Literature DB >> 8021999

Loss of elasticity in dysfunctional bladders: urodynamic and histochemical correlation.

E H Landau1, V R Jayanthi, B M Churchill, E Shapiro, R F Gilmour, A E Khoury, E J Macarak, G A McLorie, R E Steckler, B A Kogan.   

Abstract

To store adequate volumes of urine at low safe pressures an elastic bladder wall is required. We developed 2 new techniques to measure this ability in our urodynamic laboratory: pressure specific bladder volume, which measures the bladder capacity at a given pressure, and dynamic analysis of bladder compliance. Recently, morphometric and histochemical techniques have been used to determine the relative volume of connective tissue in the bladder wall and to measure the 2 major types (I and III) of collagen within the bladder wall. These methods quantitate 3 parameters of bladder ultrastructure: 1) relative volume of per cent connective tissue, 2) ratio of connective tissue to smooth muscle and 3) ratio of type III to type I collagen. These parameters have been shown to be abnormally elevated in patients with dysfunctional bladders compared to normals. The purpose of the study was to describe the ultrastructural changes that occur in the wall of dysfunctional bladders and to determine the ability of these new urodynamic techniques to detect reliably the clinical effect of these histological changes. The study included 29 consecutive patients with dysfunctional bladders necessitating bladder augmentation. All patients had upper tract changes and/or were incontinent despite treatment with clean intermittent catheterization and pharmacotherapy. Preoperative urodynamic evaluation included measurement of the total bladder capacity, pressure specific bladder volume and dynamic analysis of bladder compliance. Full thickness bladder biopsies were obtained from the dome of the bladders during augmentation. The per cent connective tissue and the ratio of connective tissue to smooth muscle were determined for all patients, and 4 unselected patients from this group had the ratio of type III to type I collagen determined. These histological results were compared to previously established normal values. All 29 patients had a decreased pressure specific bladder volume and dynamic analysis of bladder compliance, whereas 9 had a normal total bladder capacity. The per cent connective tissue was 35.19 +/- 2.84 and ratio of connective tissue to smooth muscle was 0.60 +/- 0.08 compared to normal values of 10.6 +/- 0.020 and 0.131 +/- 0.021, respectively (p < 0.05). Ratio of type III to type I collagen was also significantly elevated in the 4 samples analyzed (30.53 +/- 1.37 versus 24.00 +/- 2.50, p < 0.05). We conclude that poor storage function of poorly compliant bladders is secondary to an alteration in the connective tissue content of the bladder wall. Furthermore, these pathological ultrastructural changes are universally reflected by an abnormally low pressure specific bladder volume and dynamic analysis of bladder compliance. This strong association validates the use of these parameters and suggests that they are urodynamic indicators of a loss of elasticity in bladder wall.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021999     DOI: 10.1016/s0022-5347(17)32685-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  Local renin-angiotensin systems in the genitourinary tract.

Authors:  Craig Comiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-13       Impact factor: 3.000

2.  Intravesical oxybutynin protects the vesical wall against functional and smooth muscle changes in rabbits with detrusor overactivity.

Authors:  Armando Polido Júnior; José Mateus Costa; Tânia Munhoz; Francisco José Sampaio; Luiz Eduardo Macedo Cardoso; João Luiz Amaro
Journal:  Int Urogynecol J       Date:  2010-07-14       Impact factor: 2.894

3.  A pilot study to measure dynamic elasticity of the bladder during urodynamics.

Authors:  Andrew F Colhoun; Adam P Klausner; Anna S Nagle; Ashley W Carroll; Robert W Barbee; Paul H Ratz; John E Speich
Journal:  Neurourol Urodyn       Date:  2016-05-31       Impact factor: 2.696

4.  Fgfr2 is integral for bladder mesenchyme patterning and function.

Authors:  Y Ikeda; I Zabbarova; C M Schaefer; D Bushnell; W C De Groat; A Kanai; C M Bates
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

Review 5.  The bladder extracellular matrix. Part I: architecture, development and disease.

Authors:  Karen J Aitken; Darius J Bägli
Journal:  Nat Rev Urol       Date:  2009-11       Impact factor: 14.432

6.  Cardiovascular risk independently predicts small functional bladder storage capacity.

Authors:  Thomas F Monaghan; Connelly D Miller; Christina W Agudelo; Syed N Rahman; Karel Everaert; Lori A Birder; Alan J Wein; Jeffrey P Weiss; Jason M Lazar
Journal:  Int Urol Nephrol       Date:  2020-08-17       Impact factor: 2.370

7.  Bladder wall thickness in the assessment of neurogenic bladder: a translational discussion of current clinical applications.

Authors:  Renea M Sturm; Earl Y Cheng
Journal:  Ann Transl Med       Date:  2016-01

8.  The use of bi-layer silk fibroin scaffolds and small intestinal submucosa matrices to support bladder tissue regeneration in a rat model of spinal cord injury.

Authors:  Yeun Goo Chung; Khalid Algarrahi; Debra Franck; Duong D Tu; Rosalyn M Adam; David L Kaplan; Carlos R Estrada; Joshua R Mauney
Journal:  Biomaterials       Date:  2014-06-07       Impact factor: 12.479

9.  Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice.

Authors:  Tristan M Nicholson; Emily A Ricke; Paul C Marker; Joseph M Miano; Robert D Mayer; Barry G Timms; Frederick S vom Saal; Ronald W Wood; William A Ricke
Journal:  Endocrinology       Date:  2012-09-04       Impact factor: 4.736

10.  Ultrasound-estimated bladder weight in healthy children.

Authors:  Boris Brkljacić; Andrea Cvitković Kuzmić; Romana Dmitrović
Journal:  Eur Radiol       Date:  2004-03-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.